Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · Real-Time Price · USD

3.650

+0.220 (6.41%)

At close: Dec 19, 2025, 4:00 PM EST

3.630

-0.020 (-0.55%)

After-hours: Dec 19, 2025, 6:03 PM EST

Larimar Therapeutics Employees

Larimar Therapeutics had 65 employees as of December 31, 2024. The number of employees increased by 23 or 54.76% compared to the previous year.

Employees

65

Change (1Y)

23

Growth (1Y)

54.76%

Revenue / Employee

n/a

Profits / Employee

-$2,030,754

Market Cap

312.40M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	65	23	54.76%
Dec 31, 2023	42	16	61.54%
Dec 31, 2022	26	-5	-16.13%
Dec 31, 2021	31	3	10.71%
Dec 31, 2020	28	12	75.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

LRMR News

3 days ago - Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
18 days ago - Top 3 Health Care Stocks That May Rocket Higher In December - Benzinga
6 weeks ago - Larimar Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
2 months ago - Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR - PRNewsWire
2 months ago - LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
2 months ago - Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR - Business Wire
2 months ago - Larimar Therapeutics, Inc. - Special Call - Seeking Alpha
2 months ago - Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study - Benzinga